Geneos Wealth Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-141
Closed -$836 – 3014
2025
Q2
$836 Sell
141
-218
-61% -$1.31K ﹤0.01% 3031
2025
Q1
$2.95K Buy
359
+263
+274% +$2.21K ﹤0.01% 2664
2024
Q4
$793 Hold
96
– – ﹤0.01% 2820
2024
Q3
$734 Buy
+96
New +$884 ﹤0.01% 2501
2022
Q3
– Sell
-40
Closed – – 2456
2022
Q2
$0 Hold
40
– – ﹤0.01% 2744
2022
Q1
$0 Buy
+40
New +$505 ﹤0.01% 2929
2018
Q4
– Sell
-6,728
Closed -$115K – 2463
2018
Q3
$115K Buy
+6,728
New +$116K 0.01% 839
2017
Q1
– Sell
-72
Closed -$1K – 2121
2016
Q4
$1K Hold
72
– – ﹤0.01% 1985
2016
Q3
$1K Buy
+72
New +$1.45K ﹤0.01% 1912

Other funds holding PTEN

Geneos Wealth Management's PTEN Position: Q3 2025 in Review

Geneos Wealth Management sold out of Patterson-UTI (PTEN) in Q3 2025, closing a stake of 141 shares — an estimated $836 sold.

Geneos Wealth Management first reported a position in PTEN in Q3 2016 and held it in 9 quarters. The position peaked at $115K in Q3 2018. 368 funds tracked by Wall St. Rank hold PTEN as of Q3 2025.

  • Geneos Wealth Management reported no remaining Patterson-UTI position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 141 Patterson-UTI shares in Q3 2025, an estimated $836.
  • Geneos Wealth Management first reported a position in Patterson-UTI in Q3 2016 and held it in 9 quarters.
  • Geneos Wealth Management's Patterson-UTI position peaked at $115K in Q3 2018.
  • 368 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.